Wynzora is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Mc2 Therapeutics Ltd. The primary component is Calcipotriene; Betamethasone Dipropionate.
Product ID | 73499-001_252abab8-2793-46c6-9af0-7a88ecf41a36 |
NDC | 73499-001 |
Product Type | Human Prescription Drug |
Proprietary Name | Wynzora |
Generic Name | Calcipotriene And Betamethasone Dipropionate |
Dosage Form | Cream |
Route of Administration | TOPICAL |
Marketing Start Date | 2021-06-30 |
Marketing Category | NDA / |
Application Number | NDA213422 |
Labeler Name | MC2 Therapeutics Ltd |
Substance Name | CALCIPOTRIENE; BETAMETHASONE DIPROPIONATE |
Active Ingredient Strength | 50 ug/g; mg/g |
Pharm Classes | Vitamin D [CS],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-06-30 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
73499-001 | Wynzora | Calcipotriene and Betamethasone dipropionate |
0781-7165 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | calcipotriene and betamethasone dipropionate |
45802-889 | calcipotriene and betamethasone dipropionate | calcipotriene and betamethasone dipropionate |
45802-989 | Calcipotriene and Betamethasone Dipropionate | calcipotriene and betamethasone dipropionate |
51672-1402 | Calcipotriene and Betamethasone Dipropionate | Calcipotriene and Betamethasone Dipropionate |
63629-8618 | calcipotriene and betamethasone dipropionate | calcipotriene and betamethasone dipropionate |
63629-8619 | calcipotriene and betamethasone dipropionate | calcipotriene and betamethasone dipropionate |
63646-040 | calcipotriene and betamethasone dipropionate | calcipotriene and betamethasone dipropionate |
66993-937 | Calcipotriene and Betamethasone Dipropionate | Calcipotriene and Betamethasone Dipropionate |
66993-938 | Calcipotriene and Betamethasone Dipropionate | Calcipotriene and Betamethasone Dipropionate |
50222-302 | ENSTILAR | calcipotriene and betamethasone dipropionate |
50222-227 | Taclonex | calcipotriene and betamethasone dipropionate |
50222-501 | TACLONEX | calcipotriene and betamethasone dipropionate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
WYNZORA 79258125 not registered Live/Pending |
Horten Advokatpartnerselskab 2019-02-26 |